Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.26M Buy
74,855
+12,217
+20% +$712K 0.49% 74
2026
Q2
$3.64M Buy
62,638
+42,527
+211% +$2.31M 0.59% 4
2026
Q1
$1.17M Buy
20,111
+3,929
+24% +$213K 0.43% 96
2025
Q4
$747K Buy
+16,182
New +$724K 0.54% 47

Other funds holding PCVX

Odyssean LLC's PCVX Position: Q3 2026 in Review

Odyssean LLC increased its Vaxcyte (PCVX) stake by 20% in Q3 2026, buying an estimated $712K and bringing the position to 74,855 shares worth $4.26M. The position accounts for 0.49% of the portfolio, ranked #74.

Odyssean LLC first reported a position in PCVX in Q4 2025 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Odyssean LLC held 74,855 shares of Vaxcyte worth $4.26M as of Q3 2026.
  • Odyssean LLC bought 12,217 Vaxcyte shares in Q3 2026, an estimated $712K.
  • Vaxcyte made up 0.49% of Odyssean LLC's portfolio in Q3 2026, its #74 holding.
  • Odyssean LLC first reported a position in Vaxcyte in Q4 2025 and has held it in 4 quarters since.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.